Article
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma
12 May 2017
Abstract excerpt
BACKGROUND: Cutaneous melanoma is the deadliest skin cancer, with an increasing incidence and mortality rate. Currently, staging of patients with primary melanoma is performed using histological biomarkers such as tumor thickness and ulceration. As disruption of the epigenomic landscape is recognized as a widespread feature inherent in tumor development and progression, we aimed to identify novel biomarkers...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
